Bank of New York Mellon’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $65M | Buy |
|
|||||
|
2025
Q2 | $58.6M | Buy |
|
|||||
|
2025
Q1 | $52M | Sell |
|
|||||
|
2024
Q4 | $86.5M | Sell |
|
|||||
|
2024
Q3 | $94M | Sell |
|
|||||
|
2024
Q2 | $99.2M | Buy |
|
|||||
|
2024
Q1 | $104M | Sell |
|
|||||
|
2023
Q4 | $93.8M | Sell |
|
|||||
|
2023
Q3 | $80.8M | Buy |
|
|||||
|
2023
Q2 | $85.1M | Sell |
|
|||||
|
2023
Q1 | $84.1M | Sell |
|
|||||
|
2022
Q4 | $92.3M | Sell |
|
|||||
|
2022
Q3 | $95M | Sell |
|
|||||
|
2022
Q2 | $117M | Buy |
|
|||||
|
2022
Q1 | $149M | Buy |
|
|||||
|
2021
Q4 | $198M | Buy |
|
|||||
|
2021
Q3 | $194M | Buy |
|
|||||
|
2021
Q2 | $157M | Sell |
|
|||||
|
2021
Q1 | $149M | Sell |
|
|||||
|
2020
Q4 | $137M | Sell |
|
|||||
|
2020
Q3 | $125M | Sell |
|
|||||
|
2020
Q2 | $99.8M | Sell |
|
|||||
|
2020
Q1 | $74.4M | Sell |
|
|||||
|
2019
Q4 | $125M | Sell |
|
|||||
|
2019
Q3 | $127M | Sell |
|
|||||
|
2019
Q2 | $139M | Buy |
|
|||||
|
2019
Q1 | $95.1M | Sell |
|
|||||
|
2018
Q4 | $75.8M | Sell |
|
|||||
|
2018
Q3 | $102M | Sell |
|
|||||
|
2018
Q2 | $88.1M | Sell |
|
|||||
|
2018
Q1 | $87.2M | Buy |
|
|||||
|
2017
Q4 | $87.9M | Sell |
|
|||||
|
2017
Q3 | $87.8M | Sell |
|
|||||
|
2017
Q2 | $85M | Sell |
|
|||||
|
2017
Q1 | $84.6M | Sell |
|
|||||
|
2016
Q4 | $72.5M | Buy |
|
|||||
|
2016
Q3 | $78.4M | Sell |
|
|||||
|
2016
Q2 | $78.9M | Sell |
|
|||||
|
2016
Q1 | $73M | Buy |
|
|||||
|
2015
Q4 | $76.3M | Buy |
|
|||||
|
2015
Q3 | $58.4M | Buy |
|
|||||
|
2015
Q2 | $61.7M | Buy |
|
|||||
|
2015
Q1 | $68.9M | Buy |
|
|||||
|
2014
Q4 | $54.9M | Buy |
|
|||||
|
2014
Q3 | $50.6M | Buy |
|
|||||
|
2014
Q2 | $44.1M | Sell |
|
|||||
|
2014
Q1 | $54.7M | Sell |
|
|||||
|
2013
Q4 | $51.2M | Sell |
|
|||||
|
2013
Q3 | $45.8M | Sell |
|
|||||
|
2013
Q2 | $59M | Buy |
|